CPT Code 90734 | Description & Clinical Information
CPT 90734 describes the administration of a meningococcal conjugate vaccine, either MenACWY-D or MenACWY-CRM, which protects against four strains of meningococcal viruses that can cause serious infections such as meningitis and septicemia.
The CPT book defines CPT code 90734 as: “Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use”.
The procedure described by CPT code 90734 involves the administration of a meningococcal conjugate vaccine to provide immunity against serogroups A, C, W, and Y, the strains known to cause the majority of meningococcal diseases. During the procedure, the healthcare provider discusses the available immunization options with the parent, guardian, or patient, highlighting the risks and benefits of each. The potential side effects are also reviewed to ensure that the patient is fully informed before making a decision.
The vaccine comes in two different carrier types – MenACWYD or MenACWYCRM – and the appropriate one is selected based on the patient’s age, availability, and approved licensing. Once the patient is ready to receive the vaccine, the provider administers it intramuscularly, usually in the deltoid muscle of the upper arm.
Getting vaccinated is an essential step in protecting oneself against meningococcal diseases, which can be severe and even fatal. The meningococcal conjugate vaccine helps the body develop immunity against the bacteria responsible for these infections. Meningococcal disease can cause meningitis, which is an inflammation of the membranes that surround the brain and spinal cord. It can also cause sepsis, which is a serious bloodstream infection.
The meningococcal conjugate vaccine is highly effective, with up to 90% protection against the targeted strains. Although it is not a guarantee against all strains of meningococcal disease, the vaccine is an essential preventive measure that can save lives.
Some of the common side effects of the vaccine include pain, redness, and swelling at the injection site, as well as fever, nausea, and headache. Generally, these side effects are mild and resolve on their own within a few days.
The vaccine is recommended for all children and adolescents between the ages of 11 and 18. College students living in dormitories are also advised to receive the vaccine, as are people traveling to areas where meningococcal disease is prevalent.
In conclusion, the meningococcal conjugate vaccine is an effective preventive measure that can help protect against meningococcal disease. The procedure described by CPT code 90734 involves discussing the options and potential side effects with the patient, selecting the appropriate carrier type, and administering the vaccine intramuscularly. It is essential to get vaccinated, especially for children and adolescents, college students, and travelers to areas with a high incidence of meningococcal disease.
Return to all the CPT codes for vaccines, toxoids.